Trials / Completed
CompletedNCT02394509
HOBSCOTCH Phase II
HOBSCOTCH Phase II: A Pragmatic Study of HOBSCOTCH in New England.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- Dartmouth-Hitchcock Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the feasibility and efficacy of the home-based cognitive self-management program "HOBSCOTCH" delivered at four New England medical centers. It will test the long-term impact and cost-effectiveness of HOBSCOTCH, and whether it can be delivered from a distance utilizing e-health tools for parts of the program.
Detailed description
HOBSCOTCH (Home Based Self-management and Cognitive Training Changes lives) is a home-based self-management program to treat cognitive symptoms and improve quality of life, while minimizing the barriers of access to care. The program is based on Problem Solving Therapy (PST) and teaches problem solving strategies and compensatory mechanisms to help manage cognitive dysfunction and enhance quality of life. HOBSCOTCH Phase II is a replication study of the original HOBSCOTCH study, designed to translate the findings of HOBSCOTCH into a real world setting. This is a multi-center study, with the HOBSCOTCH intervention being implemented at four epilepsy clinics in New England.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Home Based Self-management and Cognitive Training Changes lives (HOBSCOTCH) | HOBSCOTCH is a home-based self-management program to treat cognitive symptoms and improve quality of life, while minimizing the barriers of access to care. The program is based on Problem Solving Therapy (PST) and teaches problem solving strategies and compensatory mechanisms to help manage cognitive dysfunction and enhance quality of life. |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2019-09-01
- Completion
- 2019-09-01
- First posted
- 2015-03-20
- Last updated
- 2020-08-20
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02394509. Inclusion in this directory is not an endorsement.